Han, Rui <br/><br/>
Aspirin sensitizes osimertinib-resistant NSCLC cells in vitro and in vivo via Bim-dependent apoptosis induction.  [electronic resource] 

 -  Molecular oncology  06 2020 
 - 1152-1169 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-0261 
<br/><br/><label>Standard No.: </label>10.1002/1878-0261.12682  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acrylamides--pharmacology<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Aniline Compounds--pharmacology<br/>Animals<br/>Apoptosis--drug effects<br/>Aspirin--pharmacology<br/>Bcl-2-Like Protein 11--metabolism<br/>Carcinoma, Non-Small-Cell Lung--diagnostic imaging<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>ErbB Receptors--genetics<br/>Female<br/>Forkhead Box Protein O3--metabolism<br/>Humans<br/>Lung Neoplasms--diagnostic imaging<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Middle Aged<br/>Mutation--genetics<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Signal Transduction--drug effects<br/>Tomography, X-Ray Computed<br/>Xenograft Model Antitumor Assays